Homepage

Neonc Technologies Holdings, Inc.

NTHI NASDAQ Categories PDF
Healthcare · Biotechnology · United States · Updated May 11, 1:55pm
$5.31
Price
$106.1M
Market Cap
8
Employees
0.19
Beta
Amir Farrokh Heshmatpour
CEO
Business Description

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Business History
Price Overview
Last updated: May 11, 2026 1:55pm (just now)
$5.31
-0.15 (-2.66%)
Day Range
$5.02 – $5.75
52-Week Range
$3.20 – $12.99
50-Day MA
$6.70
200-Day MA
$8.22
Volume
86,803.49
Analyst Price Targets
Low $15.00
Consensus $15.00
High $15.00
(1 analysts)
Share Structure
Outstanding 19,995,000.00
Float 4,409,012.00
Free Float 22.1%
Low free float — 22.1% of shares trade freely, ~77.9% held by insiders/institutions
Below average liquidity. Large orders can move the price significantly. Insiders or strategic holders control the majority — watch for lockup expirations or secondary offerings.
Small absolute float (4.4M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-1.64
Stock Price: $5.31
EPS (Diluted): -3.23
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
-9.07
Stock Price: $5.31
Total Equity: -$17.51M
Shares: 19,211,745
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-1.72
Market Cap: $106.07M
Total Debt: $5.95M
Cash: $58,729
EBITDA: -$59.61M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$165.1M
Market Cap: $106.07M
Total Debt: $5.95M
Cash: $58,729
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
100.0%
Gross Profit: $39,990
Revenue: $39,990
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-145,459.4%
Operating Income: -$58.17M
Revenue: $39,990
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-155,404.4%
Net Income: -$62.15M
Revenue: $39,990
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
534.4%
Net Income: -$62.15M
Total Equity: -$17.51M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
571.0%
Operating Income: -$58.17M
Tax Rate: 0.0%
Equity: -$17.51M
Total Debt: $5.95M
Cash: $58,729
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
0.07
Current Assets: $1.39M
Current Liabilities: $20.04M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
-0.34
Short-Term Debt: $5.95M
Long-Term Debt: $0.00
Total Debt: $5.95M
Total Equity: -$17.51M
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$0.00
Revenue: $39,990
Shares: 19,211,745
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$-0.91
Total Equity: -$17.51M
Shares: 19,211,745
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-1.09
Operating CF: -$20.36M
CapEx: -$500,000
Shares: 19,211,745
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $5.31
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$62.15M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares NTHI against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2025
Revenue $39,990
Cost of Revenue $0
Gross Profit $39,990
Operating Expenses $58.2M
Operating Income -$58.2M
Net Income -$62.1M
EBITDA -$59.6M
EPS $-3.23
EPS (Diluted) —
Balance Sheet (Annual)
Metric 2025
Cash & Equivalents $58,729
Total Current Assets $1.4M
Total Assets $2.8M
Current Liabilities $20.0M
Long-Term Debt $0
Total Liabilities $20.3M
Total Equity -$17.5M
Retained Earnings -$112.8M
Cash Flow (Annual)
Metric 2025
Operating Cash Flow -$20.4M
Capital Expenditure $-500,000
Free Cash Flow -$20.9M
Acquisitions (net) $0
Debt Repayment —
Dividends Paid —
Stock Buybacks $0
Net Change in Cash $-6,164
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $39,990
$39,990 – $39,990
 $39,990
$39,990 – $39,990
 $39,990
$39,990 – $39,990
 $92.1M
$92.1M – $92.1M
EBITDA $-39,990
$-39,990 – $-39,990
 $-39,990
$-39,990 – $-39,990
 $-39,990
$-39,990 – $-39,990
 -$92.1M
-$92.1M – -$92.1M
Net Income -$10.2M
-$10.2M – -$10.2M
 -$10.2M
-$10.2M – -$10.2M
 -$10.4M
-$10.4M – -$10.4M
 -$147.7M
-$147.7M – -$147.7M
EPS — — — —
Insider Trading (Recent)
Date Insider Type Shares Price Value
2025-11-24 Heshmatpour Amir F P-Purchase 6,000.00 $6.51 $39,060
2025-11-21 Heshmatpour Amir F P-Purchase 4,000.00 $6.50 $26,000
2025-11-21 Heshmatpour Amir F P-Purchase 20,000.00 $5.98 $119,600
2025-11-12 CHIANG MING-FU (ALAN) 0.00 $0.00 $0
2025-11-12 CHIANG MING-FU (ALAN) 0.00 $0.00 $0
2025-11-12 CHIANG MING-FU (ALAN) 0.00 $0.00 $0
2025-11-12 CHIANG MING-FU (ALAN) 0.00 $0.00 $0
2025-11-12 CHIANG MING-FU (ALAN) 0.00 $0.00 $0
2025-11-20 Neman-Ebrahim Yousha P-Purchase 1,100.00 $6.69 $7,359
2025-06-05 Neman-Ebrahim Yousha 0.00 $0.00 $0
2025-11-06 Heshmatpour Amir F A-Award 1,200,000.00 $0.00 $0
2025-08-18 PURI ISHWAR KANWAR 0.00 $0.00 $0
2025-06-05 Neman-Ebrahim Yousha A-Award 133,000.00 $0.00 $0
2025-06-05 Neman-Ebrahim Yousha A-Award 67,000.00 $0.00 $0
2025-06-05 Neman-Ebrahim Yousha 0.00 $0.00 $0
2025-05-23 Heshmatpour Amir F P-Purchase 2,000.00 $7.39 $14,785
2025-05-22 CHEN THOMAS C P-Purchase 2,709.00 $7.38 $20,000
2025-05-21 CHEN THOMAS C P-Purchase 2,759.00 $7.25 $20,002
2025-05-22 GARNETT KEITHLY P-Purchase 675.00 $7.29 $4,921
2025-05-19 GARNETT KEITHLY P-Purchase 135.00 $7.23 $976
Community AI Feedback
Sign in to Contribute
No community reviews yet for NTHI. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27